|
|
New understanding of pathogenesis of steroid induced osteonecrosis of the femoral head |
DENG Shuang PENG Hao |
Department of Orthopedics, Renmin Hospital of Wuhan University, Hubei Province,Wuhan 430000, China |
|
|
Abstract The use of glucocorticoids is the most common non-traumatic cause of osteonecrosis of the femoral head. Studies have shown that glucocorticoids can act directly or indirectly. Direct effects include inhibition of osteoblast and osteoclast precursor formation, apoptosis of osteoblasts and osteocytes, prolongation of osteoclast lifespan and apoptosis of endothelial cells. Indirect effects include increasing the risk of clot formation, inhibiting angiogenesis, interfering with bone repair, causing local vessel contraction, promoting lipogenesis in the bone marrow and increasing intramedullary pressure. Multiple pathway activation leads to the decrease of blood supply of the femoral head, resulting in osteonecrosis. Besides, there are individual differences in steroid sensitivity and other underlying mechanisms. The disease model is a multiple hit theory. The more risk factors, the greater probability of disease. More work is needed to better discover the pathomechanisms of glucocorticoids in osteonecrosis, so as to provide better choice for clinical treatment.
|
|
|
|
|
[1] Assouline-Dayan Y,Chang C,Greenspan A,et al. Pathog?鄄enesis and natural history of osteonecrosis [J]. Semin Art?鄄hritis Rheum,2002,32(2):94-124.
[2] Felson DT,Anderson JJ. Across-study evaluation of association between steroid dose and bolus steroids and avascular necrosis of bone [J]. Lancet,1987,1(8538):902-906.
[3] Zadegan F,Raould A,Bizot P,et al. Osteonecrosis after allogeneic bone marrow transplantation [J]. Clin Orthop Relat Res,2008,466(2):287-293.
[4] Kerachian MA,Harvey EJ,Cournoyer D,et al. Avascular necrosis of the femoral head:vascular hypotheses [J]. Endothelium,2006,13(4):237-244.
[5] Bejar J,Peled E,Boss JH,et al. Vasculature deprivation-induced osteonecrosis of the rat femoral head as a model for therapeutic trials [J]. Theor Biol Med Model,2005,2:24.
[6] Calder JD,Buttery L,Revell PA,et al. Apoptosis——a significant cause of bone cell death in osteonecrosis of the femoral head [J]. J Bone Joint Surg Br,2004,86(8):1209-1213.
[7] Weinstein RS,Chen JR,Powers CC,et al. Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids [J]. J Clin Invest,2002,109(8):1041-1048.
[8] Weinstein RS,Jilka RL,Parfitt AM,et al. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids,Potential mechanisms of their deleterious effects on bone [J]. J Clin Invest,1998, 102(2):274-282.
[9] Zalavras C,Shah S,Birnbaum MJ,et al. Role of apoptosis in glucocorticoid-induced osteoporosis and osteonecrosis [J]. Crit Rev Eukaryot Gene Expr,2003,13(2-4):221-235.
[10] Harper RN,Moore MA,Marr MC,et al. Arteriolar rarefaction in the conjunctiva of human essential hypertensives [J]. Microvasc Res,1978,16(3):369-372.
[11] Boss JH,Misselevich I. Osteonecrosis of the femoral head of laboratory animals:the lessons learned from a comparative study of osteonecrosis in man and experimental animals [J]. Vet Pathol,2003,40(4):345-354.
[12] He W,Xu C,FanY,et al. Effects of the Chinese drugs for activating blood circulation on plasma TXB2 and 6-keto-PGF1alpha contents in rabbits with glucocorticoid-induced femoral head necrosis [J]. J Tradit Chin Med,2004, 24(3):233-237.
[13] Gray E,Thomas S,Mistry Y,et al. Inhibition of tissue factor and cytokine release [J]. Haemostasis,1996,26(Suppl 1):92-95.
[14] Minneci PC,Deans KJ,Banks SM,et al. Meta-analysis:the effect of steroids on survival and shock during sepsis depends on the dose [J]. Ann Intern Med,2004,141(1):47-56.
[15] Van Giezen JJ,Jansen JW. Correlation of in vitro and in vivo decreased fibrinolytic activity caused by dexamethasone [J]. Ann N Y Acad Sci,1992,667:199-201.
[16] Van Giezen JJ,Brakkee JG,Dreteler GH,et al. Dexamethasone affects platelet aggregation and fibrinolytic activity in rats at different doses which is reflected by their effect on arterial thrombosis [J]. Blood Coagul Fibrinolysis,1994,5(2):249-255.
[17] Zangari M,Anaissie E,Barlogie B,et al. Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy [J]. Blood,2001,98(5):1614-1615.
[18] Smith DW. Is avascular necrosis of the femoral head the result of inhibition of angiogenesis?[J]. Med Hypotheses,1997,49(6):497-500.
[19] Yamamoto Y,Ishizu A,Ikeda H,et al. Dexamethasone increased plasminogen activator inhibitor-1 expression on human umbilical vein endothelial cells:an additive effect to tumor necrosis factor-alpha [J]. Pathobiology,2004,71(6):295-301.
[20] Yang C,Yang S,Du J,et al. Vascular endothelial growth factor gene transfection to enhance the repair of avascular necrosis of the femoral head of rabbit [J]. Chin Med J (Engl),2003,116(10):1544-1548.
[21] Yang C,Yang S,Du J,et al. Experimental study of vascular endothelial growth factor gene therapy for avascular necrosis of the femoral head [J]. J Huazhong Univ Sci Technolog Med Sci,2003,23(3):297-299,316.
[22] Li X,Jin L,Cui Q,et al. Steroid effects on osteogenesis through mesenchymal cell gene expression [J]. Osteoporos Int,2005,16(1):101-108.
[23] Wada M,Kumagai K,Murata M,et al. Warfarin reduces the incidence of osteonecrosis of the femoral head in spontaneously hypertensive rats [J]. J Orthop Sci,2004,9(6):585-590.
[24] Akaike M,Matsumoto T. Glucocorticoid-induced reduction in NO bioavailability and vascular endothelial dysfunction [J]. Clin Calcium,2007,17(6):864-870.
[25] Drescher W,Li H,Lundgaard A,et al. Endothelin-1-induced femoral head epiphyseal artery constriction is enhanced by long-term corticosteroid treatment [J]. J Bone Joint Surg Am,2006,88(Suppl 3):173-179.
[26] Drescher W,Varoga D,Liebs TR,et al. Femoral artery constriction by norepinephrine is enhanced by methylprednisolone in a rat model [J]. J Bone Joint Surg Am,2006, 88(Suppl 3):162-166.
[27] Miyanishi K,Yamamoto T,Irisa T,et al. Bone marrow fat cell enlargement and a rise in intraosseous pressure in steroid-treated rabbits with osteonecrosis [J]. Bone,2002, 30(1):185-190.
[28] Zhou Q,Li Q,Yang L,et al. Changes of blood vessels in glucocorticoid-induced avascular necrosis of femoral head in rabbits [J]. Zhonghua Wai Ke Za Zhi,2000,38(3):212-215.
[29] Yin L,Li YB,Wang YS. Dexamethasone-induced adipogenesis in primary marrow stromal cell cultures:mechanism of steroid-induced osteonecrosis [J]. Chin Med J (Engl),2006,119(7):581-588.
[30] Jones JP,Ramirez S,Doty SB. The pathophysiologic role of fat in dysbaric osteonecrosis [J]. Clin Orthop Relat Res,1993(296):256-264.
[31] Korompilias AV,Gilkeson GS,Seaber AV,et al. Hemorrhage and thrombus formation in early experimental osteonecrosis [J]. Clin Orthop Relat Res,2001(386):11-18.
[32] Koch CA,Tsigos C,Patronas NJ,et al. Cushing's disease presenting with avascular necrosis of the hip:an orthopedic emergency [J]. J Clin Endocrinol Metab,1999,84(9):3010-3012.
[33] Posan E,Harsfalvi J,Szepesi K,et al. Increased platelet activation and decreased fibrinolysis in the pathogenesis of aseptic necrosis of the femoral head [J]. Platelets,1998, 9(3-4):233-235.
[34] Ferrari P,Schroeder V,Anderson S,et al. Association of plasminogen activator inhibitor-1 genotype with avascular osteonecrosis in steroid-treated renal allograft recipients [J]. Transplantation,2002,74(8):1147-1152.
[35] Jones JP. Coagulopathies and osteonecrosis [J]. Acta Orthop Belg,1999,65(Suppl 1):5-8.
[36] Jones LC,Mont MA,Le TB,et al. Procoagulants and osteonecrosis [J]. J Rheumatol,2003,30(4):783-791.
[37] Asano T,Takahashi KA,FujiokM,et al. Relationship between postrenal transplant osteonecrosis of the femoral head and gene polymorphisms related to the coagulation and fibrinolytic systems in Japanese subjects [J]. Transplantation,2004,77(2):220-225.
[38] Seguin C,Kassis J,Busque L,et al. Non-traumatic necrosis of bone(osteonecrosis)is associated with endothelial cell activation but not thrombophilia [J]. Rheumatology (Oxford),2008,47(8):1151-1155.
[39] Khan A,Illiffe G,Houston DS,et al. Osteonecrosis in a patient with Crohn's disease unrelated to corticosteroid use [J]. Can J Gastroenterol,2001,15(11):765-768.
[40] Freeman HJ,Kwan WC. Brief report:non-corticosteroid-associated osteonecrosis of the femoral heads in two patients with inflammatory bowel disease [J]. N Engl J Med,1993,329(18):1314-1316.
[41] Koller E,Mann M,Malozowski S,et al. Aseptic necrosis in HIV seropositive patients:a possible etiologic role for megestrol acetate [J]. AIDS Patient Care STDS,2000,14(8):405-410.
[42] Scribner AN,Troia-Cancio PV,Cox BA,et al. Osteonecrosis in HIV:a case-control study [J]. J Acquir Immune Defic Syndr,2000,25(1):19-25.
[43] Schulte CM,Beelen DW. Vascular osteonecrosis after allogeneic hematopoietic stem-cell transplantation:diagnosis and gender matter [J]. Transplantation,2004,78(7):1055-1063. |
|
|
|